Evercore ISI lowers Karman Holdings stock price target on valuation By Investing.com

Evercore ISI cut Karman Holdings' price target to $100 from $125 but kept an Outperform rating after the company posted Q1 revenue of $151.2 million and EPS of $0.11, roughly in line with expectations. Management raised 2026 revenue guidance to $720 million-$735 million and EBITDA guidance to $208.5 million-$219.5 million, supported by funded backlog above $1 billion, up 28% q/q and 61% y/y. The company also cited strong defense-related demand and ongoing capacity expansion, with another bolt-on acquisition possible before year-end.

Analysis

KRMN’s setup is less about the current print and more about the compounding of backlog visibility, funded program conversion, and capacity expansion. The key second-order effect is that a rising mix of long-dated, customer-committed demand reduces execution risk on the new facility buildout and supports a higher terminal margin than the market is likely assigning to a fast-growing defense supplier. That said, the bigger M&A contribution means reported growth is still partly inorganic, so the stock’s multiple should stay sensitive to deal quality and integration discipline rather than just top-line momentum.

The most important catalyst is not the next quarter but the next 6-12 months of funding cadence from defense customers and whether Utah/Gulfport ramp without margin leakage. If production ramps smoothly, KRMN can turn today’s backlog into a self-reinforcing “capacity first, margin later” story; if ramp timing slips, the market will focus on working capital drag and execution overgrowth. A second-order positive is that the written multi-year commitments should improve the company’s financing profile and bargaining power with suppliers, potentially lowering input volatility as volumes rise.

The contrarian view is that the move may already be partially de-risked by the market’s willingness to pay up for defense-adjacent compounders. Cutting the target while keeping Outperform suggests the street is still cautious on valuation, implying upside may require evidence of organic growth accelerating above the low-20s rather than simply maintaining current momentum. Competitively, smaller defense vendors without committed backlog or expansion capacity are most vulnerable if KRMN keeps locking in multi-year demand and uses acquisitions to fill product gaps.

Near term, the main risks are execution slippage, integration missteps from another bolt-on, and any stall in customer funding that could defer backlog conversion by 1-2 quarters. Over a 12-24 month horizon, the stock’s re-rating depends on whether margin expansion proves durable as the new facilities come online, not just whether revenue keeps growing at a high rate.

Key Decisions for Investors

• Stay long KRMN on pullbacks over the next 2-6 weeks, but size it as a quality-growth defense compounder rather than a pure momentum trade; upside is tied to backlog conversion and facility ramp, with downside if execution slips.
• Pair trade: long KRMN / short a lower-quality defense supplier with weaker backlog visibility and no near-term capacity expansion; this isolates the value of funded demand and operational leverage over sector beta.
• Buy 3-6 month call spreads on KRMN rather than outright calls to express upside from backlog and guidance credibility while capping valuation risk if the market remains skeptical.
• If KRMN reports any delay in Utah initial production or another acquisition before year-end, reduce exposure quickly; those are the two most likely catalysts for multiple compression within 1-2 quarters.